Experts hesitate on weight loss ETFs amid the obesity drug boom
[ad_1]
While weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category can achieve the same success.
[ad_2]
Source link
[ad_1]
While weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category can achieve the same success.
[ad_2]
Source link
